- Filed
- Jun 26, 2024 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q3 2024 · Jun 24, 2024 | 114.1M sh |
| Current Liabilities | Q3 2024 · Mar 31, 2024 | $263.75K |
| Current Liabilities | Q3 2024 · Jun 30, 2023 | $142.13K |
| Total Liabilities | Q3 2024 · Mar 31, 2024 | $470.45K |
| Total Liabilities | Q3 2024 · Jun 30, 2023 | $346.16K |
| Current Assets | Q3 2024 · Mar 31, 2024 | $141.08K |
| Current Assets | Q3 2024 · Jun 30, 2023 | $214.41K |
| Total Assets | Q3 2024 · Mar 31, 2024 | $838.64K |
| Total Assets | Q3 2024 · Jun 30, 2023 | $915.7K |
| Stockholders Equity | Q3 2024 · Dec 31, 2023 | $489.32K |
| Stockholders Equity | Q3 2024 · Sep 30, 2023 | $566.04K |
| Stockholders Equity | Q3 2024 · Mar 31, 2023 | $667.08K |
| Stockholders Equity | Q3 2024 · Dec 31, 2022 | $753.3K |
| Stockholders Equity | Q3 2024 · Sep 30, 2022 | $750.38K |
| Stockholders Equity | Q3 2024 · Jun 30, 2022 | $611.96K |
| Shares Diluted | Q3 2024 · Mar 31, 2023 | 170.2M sh |
| Shares Diluted | Q3 2024 · Mar 31, 2023 | 164.81M sh |
| Operating Cash Flow restated | Q3 2024 · Mar 31, 2023 | −$252.31K |
| Eps Diluted | Q3 2024 · Mar 31, 2023 | $0.00 |
| Eps Diluted | Q3 2024 · Mar 31, 2023 | $0.00 |
| Eps Basic | Q3 2024 · Mar 31, 2023 | $0.00 |
| Eps Basic | Q3 2024 · Mar 31, 2023 | $0.00 |
| Sga Expense | Q3 2024 · Mar 31, 2023 | $68.83K |
| Sga Expense | Q3 2024 · Mar 31, 2023 | $306.07K |
| Net Income | Q3 2024 · Mar 31, 2023 | −$138.72K |
| Net Income | Q3 2024 · Mar 31, 2023 | −$431.48K |
| Operating Income | Q3 2024 · Mar 31, 2023 | −$139.84K |
| Operating Income | Q3 2024 · Mar 31, 2023 | −$433.85K |
| Gross Profit | Q3 2024 · Mar 31, 2023 | −$69.79K |
| Gross Profit | Q3 2024 · Mar 31, 2023 | −$125.05K |
| Cost Of Revenue | Q3 2024 · Mar 31, 2023 | $100.02K |
| Cost Of Revenue | Q3 2024 · Mar 31, 2023 | $223.52K |